Work

528 Alterations in the fecal microbiota of patients with advanced cystic fibrosis–associated liver disease after 6 months of elexacaftortezacaftor-ivacaftor

Year: 2023

Type: article

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(23)01451-0

Authors: J. Duong, C. Pope, H. Hayden, C. Miller, S. Salipante, S. Rowe, G. Solomon, D. Nichols, L. Hoffman, M. Narkewicz, N. Green

Institutions: Nebraska Medical Center, Emory University, University of Washington, Mahidol University, Ramathibodi Hospital, Children's Hospital & Medical Center, Ramathibodi Chakri Naruebodindra Hospital, University of Nebraska Medical Center, Children's Healthcare of Atlanta, Children's Hospital of Philadelphia

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Children's Hospital Colorado, University of Washington, Seattle Children's Research Institute, Children’s Hospital of Wisconsin Research Institute, National Institutes of Health, Anschutz Medical Campus, University of Colorado, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G5391484550, G9000131369, Georgia Clinical & Translational Science Alliance (Georgia CTSA), A Dietary Intervention to Improve Glucose Tolerance in Adults with Cystic Fibrosis

OpenAlex ID: W4387739056

FWCI:

Cites:

Cited by:

Related to: 10